C08L 5/10
Heparin
Official title: Heparin; Derivatives thereof
C08L5/10 (Heparin) appears on 72 US grants and 131 published applications in this corpus.
Search patents in C08L- Granted patents
- 72
- Published applications
- 131
- Assignees
- 96
- Inventors
- 286
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 1 | 0 |
| 1983 | 2 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 0 |
| 2004 | 0 | 3 |
| 2005 | 1 | 1 |
| 2006 | 0 | 5 |
| 2007 | 1 | 4 |
| 2008 | 2 | 2 |
| 2009 | 1 | 3 |
| 2010 | 1 | 5 |
| 2011 | 1 | 7 |
| 2012 | 6 | 5 |
| 2013 | 4 | 9 |
| 2014 | 6 | 7 |
| 2015 | 3 | 2 |
| 2016 | 3 | 6 |
| 2017 | 4 | 4 |
| 2018 | 3 | 5 |
| 2019 | 4 | 4 |
| 2020 | 1 | 4 |
| 2021 | 4 | 8 |
| 2022 | 1 | 10 |
| 2023 | 8 | 15 |
| 2024 | 1 | 9 |
| 2025 | 4 | 9 |
| 2026 | 3 | 4 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Rapid testing mechanism and method for respiratory viral pathogens29 Sep 2026US 12,748,100 B2
- In vitro heparin and heparan sulfate compositions and methods of making and using26 May 2026US 12,636,307 B2TEGA Therapeutics, Inc.
- Agent to be used in intraocular membrane detachment surgery19 May 2026US 12,629,458 B2Fukuoka University
- Safe bovine heparin, preparation method, and application2 Dec 2025US 12,485,137 B2Heptech Pesquisa E Desenvolvimento Ltda
- Mimetics of heparin oligosaccharides5 Aug 2025US 12,378,278 B2Board of Trustees of Michigan State University
- Heparan sulfate and its mimetics as chemokine inhibitors23 Jul 2026US 2026/0207654 A1Indian Institute of Science Education and Research
- Preparation of medium molecular weight heparin9 Jul 2026US 2026/0193385 A1Glycos Biomedical Ltd
- Methods for the chemoenzymatic synthesis of low molecular weight heparin from low molecular weight heparosan11 Jun 2026US 2026/0159866 A1Otsuka Pharmaceutical Factory, Inc.
- Synthetic hexasaccharides mimics of heparin showing heparanase inhibition activity1 Jan 2026US 2026/0001967 A1Centro Alta Tecnologia Istituto Di Ricerche Chimiche E Biochimiche G. Ronzoni S.R.L.
- Heparanase inhibitors and methods of use11 Dec 2025US 2025/0375471 A1The Board of Regents of the University of Oklahoma
Most cited
By later US patents
- Method of preparing antithrombogenic medical materials130US 4,806,595 AKoken Co., Ltd. · 1989
- Ionically crosslinked hydrogels with adjustable gelation time93US 6,497,902 B1The Regents of the University of Michigan · 2002
- Glycosaminoglycan/collagen complexes and use thereof81US 7,226,611 B2Yaizu Suisankagaku Industry Co., Ltd. · 2007
- Polysaccharide gel formulation having multi-stage bioactive agent delivery51US 8,394,784 B2Allergan, Inc. · 2013
- Polysaccharide gel formulation having multi-stage bioactive agent delivery42US 8,394,783 B2Allergan, Inc. · 2013